Chemical Intelligent Physics Hybrid Exploration Rewriter – Scaffold Kinetic Intelligence
“Rewriting Chemistry with Physics-Informed Scaffold Kinetic Intelligence.”
CIPHER-SKI is a next-generation AI platform that intelligently explores chemical space to create novel, high-potential drug candidates with unprecedented speed and precision.
While most AI systems generate only minor variations of existing molecules, CIPHER-SKI excels at true scaffold hopping. It learns to creatively rewrite the core architecture of molecules by replacing small chemical patterns with diverse, drug-like fragments, and guided by an energy-driven Deep Q-Network (DQN).
This physics-informed approach doesn’t just optimize for binding affinity. It actively balances potency, energetic stability, and druggable properties (size, lipophilicity, polarity, and synthetic accessibility) to produce higher-quality leads that are more likely to succeed in later development stages.
Why CIPHER-SKI Matters
- Bold Chemical Innovation: Discovers entirely new chemical series instead of incremental analogs through explicit molecular rewriting.
- Energy-Guided Intelligence: Combines Vina docking with real quantum-mechanical energies (xTB) to favor both strong binding and physically stable molecules.
- High-Quality, Druggable Leads: Generates structurally diverse compounds optimized for potency, safety, and developability in the ideal 400 – 500 Da range.
- Speed & Efficiency: Rapidly produces thousands of patentable, connected molecules optimized for your target.
- Real-World Focus: Built with actual docking scores, medicinal chemistry principles, and energetic realism at its core.
Early results have demonstrated consistent binding scores reaching the negative double digits, while maintaining excellent drug-like properties and structural novelty.
The CIPHER-SKI Advantage We don’t just generate molecules. We intelligently rewrite them using physics-informed scaffold kinetic intelligence.
By combining powerful learning systems with principled exploration and real energetic feedback, CIPHER-SKI navigates the vast chemical universe far more effectively than traditional methods or standard generative AI; delivering leads that are both novel and set a clear roadmap for developing a commercial drug.
The result? Faster discovery. Stronger IP. Better chances of clinical success.
Ready to explore new chemical space?